CTA Meeting on Paediatric ARVs: Introducing the Global Accelerator for Paediatric Formulations
5 December 2016 | Geneva, Switzerland (By invitation only)

On 5 December 2016, the Global Pediatric Antiretroviral Commitment-to-Action (CTA) partner organizations convened key stakeholders in the paediatric ARV space to accelerate joint efforts to identify innovative approaches to fast-track development and introduce priority paediatric formulations. This meeting built on previous efforts to develop a collaborative framework to accelerate development of paediatric ARVs, and, potentially, serve as a model for tuberculosis and other disease areas.

The objectives of the meeting were to first assess the level of stakeholder support for the revised proposal for a Global Accelerator for Paediatric Formulations and, second, provided the framework is supported, to identify and generate consensus around key action steps required for its implementation. To that end, the CTA convened leaders from across the HIV community and after presenting the revised framework, two panel discussions helped better define some of the concrete steps to be taken in order to start implementing the principles of the Global Accelerator for Paediatric Formulations, at global as well as at country level. Key considerations shared during the meeting are summarized and will be used to inform the next steps to be taken during the first phase of implementation of the Global Accelerator for Paediatric Formulations.

Meeting material

  • Related documents
  • Presentations
  • Welcome
    George Siberry, Office of the U.S. Global AIDS Coordinator
  • Opening remarks
    Gottfried Hirnschall, World Health Organization
    Rev. Msgr. Robert J. Vitillo, Caritas Internationalis
  • The Global Accelerator for Paediatric Formulations: Updated framework for collaboration
    Martina Penazzato, World Health Organization and Melynda Watkins, Clinton Health Access Initiative
  • Open-floor discussion: Participant discussion of the Global Accelerator for Paediatric Formulations
    Facilitator: George Siberry, Office of the U.S. Global AIDS Coordinator
  • Panel discussion: Global actions to accelerate development and availability of key paediatric ARVs
    Facilitator: Carmen Perez Casas, UNITAID
    Participants: Mark Lallemenat, DNDi and Yodit Belew, FDA
    Elaine Abrams (IMPAACT), Devasena Gnanashanmugam (NIAID), Emmanuel Patras (Mylan Laboratories), Carlo Giaquinto (PENTA), Giancarlo Francese (Teva Pharmaceuticals), Helen McDowell (ViiV Healthcare)
  • Panel discussion: Increasing in-country demand and uptake
    Facilitator: Chip Lyons (Elizabeth Glaser Pediatric AIDS Foundation)
    Participants: Nandita Sugandhi (CHAI), Umesh Warty (CHAI), Fernando Pascual (MPP), Kedar Madhekar (Mylan Laboratories), Emer Cooke (WHO RHT)
  • Defining the next steps
    Marissa Vicari (International AIDS Society)
  • Summary and closing remarks
    Sébastien Morin (International AIDS Society)